文献速递临床试验与 GCP流行病学与生物统计

地中海饮食与正念减压对胎儿生长受限及围产结局的随机对照试验方案

Mediterranean diet, Mindfulness-Based Stress Reduction and usual care during pregnancy for reducing fetal growth restriction and adverse perinatal outcomes: IMPACT BCN (Improving Mothers for a better PrenAtal Care Trial BarCeloNa): a study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-05-24

IMPACT BCN 是一项单中心、随机、平行、开放盲法、1:1:1 分配的试验,拟纳入 1218 例 FGR 高危单胎妊娠(19.0-23.6 周),比较地中海饮食、正念减压项目和常规护理对围产结局的影响。主要目标是降低 FGR 患病率,次要目标包括减少不良围产结局及改善儿童 2 岁时神经发育和心血管状况。

要点

  • FGR 影响 7-10% 妊娠,与围产期发病和死亡、长期残疾及认知障碍风险升高相关。
  • 试验按 1:1:1 随机分为地中海饮食、正念减压和常规护理三组,主要终点为 FGR 患病率。
  • 在 30% 参与者中用特定生物标志物随机检测干预依从性,并随访至纠正年龄 2 岁。

核心结论

  • 该方案旨在评估孕期地中海饮食和正念减压干预能否降低 FGR 患病率及改善围产结局。

研究设计与样本

  • 随机平行、开放盲法、单中心试验,按 1:1:1 将 FGR 高危单胎妊娠(N=1218)随机分为三组。
  • 纳入标准依据 RCOG 标准,孕周 19.0-23.6 周,三组分别为地中海饮食、正念减压项目和常规护理。

主要发现

  • 原文未报告研究结果,仅报告研究方案。

关键数值与推荐

  • 主要目标为降低 FGR 患病率;次要目标为减少不良围产结局及改善儿童 2 岁时神经发育和心血管状况。
  • 在 30% 参与者中用特定生物标志物随机检测干预依从性。
  • 在意向性治疗和符合方案人群中进行分析。

临床怎么用

  • 该方案为孕期生活方式干预(地中海饮食和正念减压)改善围产结局提供随机对照试验依据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fetal growth restriction (FGR) affects 7-10% of all pregnancies resulting in a higher risk of perinatal morbidity and mortality, long-term disabilities, and cognitive impairment. Due to its multifactorial etiology, changes in maternal lifestyle, including suboptimal maternal diet and stress, have increasingly been associated with its prevalence. We present a protocol for the Improving Mothers for a better PrenAtal Care Trial Barcelona (IMPACT BCN), which evaluates two different maternal lifestyle strategies (improved nutrition by promoting Mediterranean diet and stress reduction program based on mindfulness techniques) on perinatal outcomes. The primary objective is to reduce the prevalence of FGR. Secondary aims are to reduce adverse perinatal outcomes and to improve neurodevelopment and cardiovascular profile in children at 2 years of age. METHODS: A randomized parallel, open-blind, single-center trial following a 1:1:1 ratio will select and randomize high-risk singleton pregnancies for FGR (N=1218), according to the criteria of the Royal College of Obstetricians and Gynaecologists (19.0-23.6 weeks' gestation), into three arms: Mediterranean diet, mindfulness-based stress reduction program, and usual care without any intervention. Compliance to the interventions will be randomly tested in 30% of participants with specific biomarkers. Maternal socio-demographic, clinical data, biological samples, and lifestyle questionnaires will be collected at enrollment and at the end of the interventions (34.0-36.6 weeks' gestation), together with a fetoplacental ultrasound and magnetic resonance. Fetoplacental biological samples and perinatal outcomes will be recorded at delivery. Postnatal follow-up is planned up to 2 years of corrected age including neurodevelopmental tests and cardiovascular assessment. Intention-to-treat and population per-protocol analysis will be performed. DISCUSSION: This is the first randomized study evaluating the impact of maternal lifestyle interventions during pregnancy on perinatal outcomes. The maternal lifestyle interventions (Mediterranean diet and mindfulness-based stress reduction program) are supported by scientific evidence, and their compliance will be evaluated with several biomarkers. TRIAL REGISTRATION: ClinicalTrials.gov NCT03166332 . Registered on April 19, 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Crovetto F, Crispi F, Borras R, et al. Mediterranean diet, Mindfulness-Based Stress Reduction and usual care during pregnancy for reducing fetal growth restriction and adverse perinatal outcomes: IMPACT BCN (Improving Mothers for a better PrenAtal Care Trial BarCeloNa): a study protocol for a randomized controlled trial. Trials. 2021. PMID: 34030703. doi:10.1186/s13063-021-05309-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。